期刊文献+

HCV感染小鼠小胶质细胞后TLR7mRNA和IL-6表达 被引量:2

Expressions of TLR7 mRNA and IL-6 in mouse microglial cells after hepatitis C virus infection
下载PDF
导出
摘要 目的通过观察丙型肝炎病毒(HCV)感染小鼠小胶质细胞BV2后Toll样受体(TLR)7 mRNA及白细胞介素(IL)-6水平的动态变化,探讨HCV对中枢神经系统(CNS)的免疫发病机制。方法用20%(体积分数)的HCV阳性血清感染BV2细胞,在感染后6、12、244、8 h收集细胞,应用实时荧光定量PCR(RT-qPCR)和ELISA法检测TLR7 mRNA和IL-6表达,同时设空白对照组和正常血清组。结果 3组BV2细胞中均有TLR7 mRNA表达;HCV阳性血清感染BV2细胞后TLR7 mRNA表达随时间延长而逐渐增高,其中在12、24、48 h时表达水平均较其他两组增高(P<0.05)。IL-6表达在HCV阳性血清组也逐渐增高,48 h时与空白对照组、正常血清组48 h时比较差异有统计学意义(P<0.05)。结论 BV2细胞可以表达TLR7 mRNA,HCV感染能上调BV2细胞TLR7 mRNA和IL-6表达。TLR7可能参与了HCV对CNS的病理生理过程。 Objective To observe the dynamic changes of TLR7 gene in mouse microglial BV2 after hepatitis C virus (HCV) infection and to explore the immunological pathogenesis of HCV. Methods BV2 cells were infected with the positive serum containing 20% HCV. Cells and supernatants were collected at 6 h, 12 h, 24 h and 48 h after infection, then TLR7 mRNA and IL-6 were detected by real time quantitative PCR (RT qPCR) and enzyme-linked immunosorbent assay (ELISA), respectively. Two control groups were included, one was without any treatment and another was treated with serum. Results TLR7 mRNA expressed in all three groups. TLR7 mRNA in the HCV-infected group increased gradually along with the time, and the increase was significant at 12 h, 24 h and 48 h in comparison with the other two control groups (P〈0.05). IL-6 in the HCV- infected group increased gradually, also, and was significantly higher at 48 h compared with other two groups (P〈0.05). Conclusions BV2 cells can express TLR7 mRNA, HCV infection can upregulate the expressions of TLR7 mRNA and IL-6 in BV2 cells. TLR7 might be involved in the HCV pathophysiology in central nervous system.
出处 《中国神经免疫学和神经病学杂志》 CAS 2011年第3期178-181,共4页 Chinese Journal of Neuroimmunology and Neurology
基金 国家自然科学基金项目(30760067) 教育部“春晖计划”基金项目(Z2008-1-75002) 宁夏医科大学博士学位学科建设开放课题项目(KF2010-34)
关键词 TOLL样受体7 白细胞介素6 肝炎病毒属 小胶质细胞 实时荧光定量PCR Toll-like receptor 7 IL 6 hepacivirus microglia RT-qPCR
  • 相关文献

参考文献9

  • 1Laskus T,Radkowski M,Bednarska A,et al.Detection and analysis of Hepatitis C virus sequences in cerebrospinal fluid[J].J Virol,2002,76(19):10064-10068.
  • 2王振海,吴庆秋,谢鹏,高志嵩,任丽娟.病毒性脑炎患者血液和脑脊液HCV RNA的检测[J].中华传染病杂志,2006,24(4):277-280. 被引量:7
  • 3Seifert F,Struffert T,Hildebrandt M,et al.In vivo detection of hepatitis C virus(HCV)RNA in the brain in a case of encephalitis:evidence for HCV neuroinvasion[J].Eur J Neurol,2008,15(3):214-218.
  • 4Wilkinson J,Radkowski M,Lasku s T,et al.Hepatitis C virus neuroinvasion:identification of infected cells[J].J Virol,2009,83(3):1312-1319.
  • 5王振海,谢鹏,孔繁元.丙型肝炎病毒对中枢神经系统损伤的研究进展[J].国际神经病学神经外科学杂志,2006,33(1):75-78. 被引量:14
  • 6Hacker H,Redecke V,Blagoev B,et al.Specificity in Toll-like receptor signaling through distinct effector functions of TRAF3 and TRAF6[J].Nature,2006,439(7073):204-207.
  • 7Bsibsi M,Ravid R,Gveric D,et al.Broad expression of Toll-like receptors in the human central nervous system[J].J Neuropathol Exp Neurol,2002,61:1013-1021.
  • 8Olson JK,Miller SD.Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs[J].J Immmunol,2004,173:3916-3924.
  • 9Lee J,Wu CC,Lee KJ,et al.Activation of anti-hepatitis C virus responses via Toll-like receptor 7[J].PNAS,2006,103(2):1828-1833.

二级参考文献26

  • 1Cacoub P, Saadoun D, Limal N, et al. Hepatitis C virus infection and mixed cryoglobulinaemia vasculitis: a review of neurological complications. AIDS, 2005, 3: S128-134.
  • 2Maggi F, Giorgi M, Fornai C, et al. Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol , 1999, 5 ( 3 ) : 319-323.
  • 3Bolay H, Soylemezoglu F, Nurlu G, et al.PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg, 1996,98(4) : 305 -308.
  • 4Attallah AM, Ibrahim GG.Immunodetection of a hepatitis C virus (HCV) antigen and Th1/Th2 cytokines in cerebrospinal fluid of meningitis patients. J Immunoassay Immunochem,2004, 25(4) : 313-320.
  • 5Annunziata P, Marroni M, Francisci D, et al.Acute transverse myelitis and hepatitis C virus. Infez Med, 2005, 13(1) : 45-47.
  • 6Grewal AK, Lopes MB, Berg CL, et al. Recurrent demyelinating myelitis associated with hepatitis C viral infection. J Neurol Sci, 2004, 224(1-2) : 101-106.
  • 7Origgi L, Vanoli M , Lunghi G, et al. Hepatitis C virus genotypes and clinical features in hepatitis C virus-related mixed cryoglobulinemia. Int J Clin Lab Res, 1998 , 28 ( 2 ) : 96-99.
  • 8Petty GW, Duffy J, Houston J, et al. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin Proc, 1996, 71 (7): 671-678.
  • 9Stohlman SA, Bergmann CC, van der Veen RC, et al. Mouse hepatitis virus-specific cytotoxic T lymphocytes protect from lethal infection without eliminating virus from the central nervous system. J Virol, 1995, 69(2) : 684-694.
  • 10Radkowski M , Wilkinson J. Search for Hepatitis C Virus Negative-Strand RNA Sequences and Analysis of Viral Sequences in the Central Nervous System: Evidence of Replication. J Virol,2002, 76(2) : 600-608.

共引文献14

同被引文献28

  • 1Adenm GJ. Dendritic ceils from bench to bedside and back[J]. Immunol Dett, 2009,122(2) : 128.
  • 2Piemonti L, Monti P, Sironi M, et al. Vitamin D3 affects differentia- tion, maturation, and function of human monoeyte-derived dendritic ceils [J]. J Inmmnol, 2000, 164(9):4443.
  • 3Grifn MD, Lutz W, Phan VA, et al. Dendritic cell modulation by lalpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor- dependent pathway that promotes a persistent state of immaturity in vitro and bt v/vo[J]. Proc Natl Acad Sci USA,2001, 98(12):6800.
  • 4Severa M, Remoli ME, Giacomini E,et al. Sensitization to TLR7 agonist in IFN-beta-preactivated dendritic cells[J]. J Immunol,2007,178(10) : 6208.
  • 5Larange A, Antonios D, Pallardy M, et al. TLR7 and TLR8 agonists trigger different sig~aaling pathways for human dendritic cell maturation [J]. J Leukoc Biol,2009,85(4) : 673.
  • 6Dickie LJ, Church LD, Coulthard LR, et al. Vitamin 1)3 down-regulates intracellular Toll-like receptor 9 expression and Toll-like receptor 9-in- duced IL-6 production in human monocytes [ J ]. Rheumatology ( Ox- ford) ,2010,49(8) : 1466.
  • 7Sz61es L, Keresztes G, Trcsik D, et al . 1,25-dihydroxyvitamin D3 Is an autonomous regulator of the transcriptional changes leading to a tolero- genic dendritic cell phenotype[J]. J Immunol, 2009,182(4) :2074.
  • 8van Halteren AG, Tysma OM, van Etten E,et al. la,25-Dihydroxyvi- tamin D3 or analogue treated dendritic cells modulate human autoreactive T cells via the selective induction of apoptosis[ J]. J Autoimmun,2004, 23(3) :233.
  • 9Unger WW, Ia~an S, Kleijwegt FS, et al. Induction of Treg by mono- cyte-defived DC modulated by vitamin D3 or dexamethasone: differential role for PD-LI[J]. Eur J lmnmnol,2009,39(11) :3147.
  • 10Yu H, Liu Y, Hart J, et al. TLR7 regulates dendritic cell-dependent B-cell responses through BlyS in immune thrombocytopenic purpura[ J]. Eur J Haematol, 2011,86(1):67.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部